February 23, 2025
Tilray Expands Medical Cannabis Portfolio in Germany #NewsGerman

Tilray Expands Medical Cannabis Portfolio in Germany #NewsGerman

Financial Insights That Matter

Tilray Brands, Inc.
Tilray Brands, Inc.

Global Leader in Medical Cannabis Launches New Cannabis Extract Products and Formulations

NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) — Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in Germany includes the introduction of an additional product size for its top-selling medical cannabis extract, along with a new formulation aimed at addressing the diverse needs of patients and healthcare providers. Recognizing the increasing demand for balanced medical cannabis extracts, which are among the top-prescribed medical cannabis extracts in Germany, Tilray Medical introduces the following:

Tilray THC50 CBD50 (25ml): A high-potency 1:1 medical cannabis extract designed for patients requiring higher cannabinoid content, offering an option for those who need stronger therapeutic effects while maintaining the same balanced THC:CBD ratio that has become in demand in Germany.

Tilray THC10 CBD10 (10ml): A new trial size version of Tilray Medical’s top selling medical cannabis extract, responding to patients and physicians demand for smaller formats that allow for more accessible initial dosing and treatment exploration.

Denise Faltischek, Chief Strategy Officer and Head of International, said, “Our unwavering focus on innovation and education, together with our dedication to patient care drives everything we do. Because of this, physicians and patients around the world trust the efficacy and safety of our products, which is evidenced by our position as the leading provider of medical cannabis extracts in Germany.  In consultation with healthcare providers, we continuously evaluate our portfolio and are developing new innovations, including these new product launches to meet diverse patient needs. “

Tilray Medical’s medical cannabis products are available with a physician’s prescription at pharmacies throughout Germany.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical, Broken Coast, Redecan, Good Supply and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Portugal and Germany. Today, Tilray Medical is a leading supplier of medical cannabis with a portfolio of brands and products designed to meet the needs of our patients worldwide.

#1a73e8;">Boost Your Financial Knowledge and Achieve Stability

Discover a growing online community dedicated to delivering financial news, tips, and strategies designed to help you manage money effectively, save smarter, and grow your investments with confidence.

#1a73e8;">Top Financial Tips for Saving and Investing

  • Personal Finance Management: Master the art of budgeting, expense tracking, and building a strong financial foundation.
  • Investment Opportunities: Stay updated on market trends, learn about stocks, and explore secure ways to grow your wealth.
  • Expert Money-Saving Advice: Access proven techniques to reduce expenses and maximize your financial potential.

Leave a Reply

Your email address will not be published. Required fields are marked *